Participant Details

Photo
First Name
Sarah
Last Name
Turpin-Nolan
Country
AUS
Technologies/Techniques Used
Animal Models, Fatty acid metabolism, Hepatocytes, Primary Cell Culture
Research Interest
Biological pathways, Diabetes, Disease models, Endocrinology, Gastrointestinal, Intracellular trafficking, Lipid metabolism and transport, Lymph/lymphatic system, Metabolism, Obesity, Signal transduction

Personal Info

Bio
Dr. Sarah Turpin-Nolan is currently a Research Fellow in the Cellular and Molecular Metabolism at the Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. Her research focuses upon the role of ceramides during metabolic disease, namely in the gastrointestinal tract, lymphatic and circulatory transport systems. Previously, Dr Turpin-Nolan discovered that reducing a specific ceramide specie in the liver could prevent diet-induced obesity and type 2 diabetes mellitus during her postdoctoral traiing in Prof. Jens Bruening's Laboratory at the Max Planck Institute for Metabolism Research. This work led to the development of inhibitors to treat type 2 diabetes mellitus. Dr Sarah Turpin-Nolan completed her PhD in the Biology of Lipid Metabolism Laboratory supervised by Prof. Matthew Watt. Her PhD investigated the Metabolic consequences of lipid-oversupply in key glucoregulatory tissues and was awarded by The University of Melbourne (Dept of Medicine & Health Sciences).